Categories Earnings, Health Care

Earnings Summary: A snapshot of Bio-Techne’s (TECH) Q4 2024 results

Biotechnology company Bio-Techne Corporation (NASDAQ: TECH) on Wednesday announced financial results for the fourth quarter of 2024, reporting a decline in profit.

  • Fourth-quarter organic revenue edged up 1% to $306.1 million; net sales moved up 2% during the three months
  • Earnings per share, including special items, dropped to $0.25 in Q4 from $0.47 last year; adjusted earnings declined to $0.49 per share from $0.55 in Q4 2023
  • Operating income for the fourth quarter decreased 52% to $45.8 million from $94.5 million a year earlier
  • Q4 operating margin declined to 15.0% from 31.4% in the prior-year quarter, hurt mainly by impairment of assets held-for-sale, restructuring, and CEO transition costs

Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.

Most Popular

Adobe (ADBE) to report Q3 earnings on Sept 12. Here’s what to expect

After delivering record-high revenues in the second quarter, Adobe Inc. (NASDAQ: ADBE) is gearing up to report third-quarter results next week. The design software maker has effectively integrated advanced AI

A look at Campbell Soup’s (CPB) expectations for fiscal year 2025

Shares of Campbell Soup Company (NASDAQ: CPB) rose over 1% on Friday. The stock has gained 21% over the past three months. The company delivered sales and earnings growth for

DOCU Earnings: DocuSign Q2 2025 profit jumps on higher revenues

DocuSign, Inc. (NASDAQ: DOCU) reported a sharp increase in adjusted earnings for the second quarter of 2025. The bottom line benefitted from a 7% increase in revenues. The eSignature service

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top